The U.S. Preventive Services Task Force (USPSTF) has done some fresh thinking on the pros and cons of screening for colorectal cancer, posting updated recommendations June 15 in JAMA.

Surgeons have used a new tumor-specific, near-infrared (NIR) fluorescent agent, combined with a dedicated camera-based imaging system, to find and resect ovarian tumors that are invisible to the naked eye and undetectable by the surgeon’s fingertips.

A preclinical study has shown that autism may trace not only to impairments in the brain but also to nerves of the extremities and, possibly, throughout the body. 

PET amyloid imaging does a fine job finding susceptibility to Alzheimer’s disease long before symptoms set in, but PET tau imaging is better at showing what’s going on once neuronal injury becomes functionally evident. 

Pride of place has its place in publicizing medical breakthroughs, and the Aussies are rightly proud of a radioactive drug developed in Melbourne and presented June 11 at SNMMI in San Diego.

Two Danish researchers have shown that it’s crucial to x-ray suspected osteoarthritis in the knee with the patient in a standing, weight-bearing position rather than a supine, non-weight-bearing position.

A new MRI-guided intervention has proven safe and efficacious in men with prostate cancer, according to a study published in the Journal of Urology and publicized by UCLA Health June 10. 

Facebook advertising can help speed patients with inflammatory back pain (IBP) toward appropriate diagnostic procedures—including imaging with MRI rather than x-ray and observation by a rheumatology specialist rather than a primary-care doc—as well as toward proper treatment.